Clinical Trial Update: Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of azithromycin on lung function in children aged 6-18 with cystic fibrosis not infected with Pseudomonas aeruginosa. Result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• ZITHROMAX (AZITHROMYCIN DIHYDRATE)

Snippet

Sponsor: CF Therapeutics Development Network Coordinating Center | Conditions: Cystic Fibrosis | Phase 4 | Status: COMPLETED | Results posted: 2015-08-19